Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/31/20 → 8/31/50 |
Funding
- Children's Hospital Boston
- Novartis Pharmaceuticals Corporation
ICON3: A Phase 3 Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
- Thompson, Alexis A (PD/PI)
Project: Research project